Trial · NCT01594333
Outcomes13
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Subjects With Major Adverse Cardiovascular Events | From randomization to trial end (April 2, 2018) up to a maximum of 5 years | All randomized subjects | participants | NUMBER |
| PRIMARY | Number of Subjects With Major Adverse Cardiovascular Event or Hospitalization for Unstable Angina That Led to Urgent Coronary Revascularization | From randomization to trial end (April 2, 2018) - up to a maximum of 5 years | All randomized participants | participants | NUMBER |
| SECONDARY | Number of Subjects With All-cause Mortality | From randomization to the trial end (April 2, 2018) up to a maximum of 5 years | All Randomized Participants | participants | NUMBER |
| SECONDARY | Number of Subjects With Major Adverse Cardiovascular Event or Any Coronary Revascularization | From randomization to the trial end (April 2, 2018) - up to a maximum of 5 years | All randomized participants | participants | NUMBER |
| SECONDARY | Number of Subjects With Hospitalization for Congestive Heart Failure | From randomization to trial end (April 2, 2018) up to a maximum of 5 years | All randomized participants | participants | NUMBER |
| SECONDARY | Number of Subjects With Major Adverse Cardiovascular Event, Coronary Revascularization, Hospitalization for Congestive Heart Failure or All Cause Mortality | From randomization to trial end (April 2, 2018) up to a maximum of 5 years | All randomized participants | participants | NUMBER |
| SECONDARY | Number of Subjects With New Onset Type 2 Diabetes | From randomization to the trial end (April 2, 2018) - up to 5 years | Randomized participants without pre-randomization diabetes | Participants | COUNT_OF_PARTICIPANTS |
| OTHER_PRE_SPECIFIED | Number of Subjects With Hospitalization for Unstable Angina That Led to Unplanned Coronary Revascularization | From randomization to the trial end (April 2, 2018) up to 5 years | All randomized participants | participants | NUMBER |
| OTHER_PRE_SPECIFIED | Number of Subjects With Coronary Revascularization | From randomization to trial end (April 2, 2018) up to 5 years | All randomized participants | participants | NUMBER |
| OTHER_PRE_SPECIFIED | Number of Subjects With Peripheral Artery Disease | From randomization to the trial end (April 2, 2018) - up to 5 years | |||
| OTHER_PRE_SPECIFIED | Number of Subjects With Deep Vein Thrombosis or Pulmonary Embolism | From randomization to the trial end (April 2, 2018) - up to 5 years | The trial was ended prematurely. There were not sufficient outcome measures for analysis | ||
| OTHER_PRE_SPECIFIED | Number of Subjects With Aortic Stenosis | From randomization to the trial end (April 2, 2018) - up to 5 years | The trial ended prematurely. There were not sufficient outcome measures for analysis. | ||
| OTHER_PRE_SPECIFIED | Number of Subjects With Atrial Fibrillation | From randomization to the trial end (April 2, 2018) - up to 5 years |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01594333/outcomes